Skip to content

Assessment of Hemostatic Profile in Liver Cirrhosis

Assessment of Hemostatic Profile in Patients With Mild to Advanced Liver Cirrhosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04265508
Enrollment
67
Registered
2020-02-11
Start date
2017-12-01
Completion date
2018-11-01
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation Disorder

Brief summary

Our study included both in- and outpatients suffering from liver cirrhosis attending the out- and inpatient care of the department of hepatology. Demographic and biochemical data as well as medical history including cause of liver cirrhosis, end stage kidney failure and medication with anticoagulants were recorded. To assess the hemostatic profile, platelet function was analyzed by multiple electrode aggregometry (MEA) using Multiplate (ADP-, ASPI- and TRAP-test) and thrombelastometry using ROTEM (EXTEM, INTEM, FIBTEM).

Interventions

OTHERAssessment of hemostatic profile

To assess the hemostatic profile, platelet function was analyzed by multiple electrode aggregometry (MEA) using Multiplate (ADP-, ASPI- and TRAP-test) and thrombelastometry using ROTEM (EXTEM, INTEM, FIBTEM)

Sponsors

Goethe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* liver cirrhosis * age of ≥ 18 years * platelet count of at least 70 / nl

Exclusion criteria

* transfusion of platelet concentrate three weeks prior to inclusion * pregnancy * age \< 18 years * missing informed consent

Design outcomes

Primary

MeasureTime frameDescription
Aggregation of plateletsVenous blood was collected via a cannula inserted into a cubital vein. Platelet function was measured by MEA using the Multiplate analyzer 15min after blood draw and after activation with commercially available standard reagentsAUC of impedance aggregometry using multiple electrode aggregometry

Secondary

MeasureTime frameDescription
Viscoelastic measurementsVenous blood was collected via a cannula inserted into a cubital vein. Thrombelastometric assays were performed 15min after blood draw.Viscoelastic measurements of ROTEM assays (EXTEM, INTEM, FIBTEM)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026